Alpha Tau Medical Stock Market Value
| DRTS Stock | USD 7.21 0.02 0.28% |
| Symbol | Alpha |
Is there potential for Biotechnology market expansion? Will Alpha introduce new products? Factors like these will boost the valuation of Alpha Tau. Projected growth potential of Alpha fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Alpha Tau listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Alpha Tau Medical is measured differently than its book value, which is the value of Alpha that is recorded on the company's balance sheet. Investors also form their own opinion of Alpha Tau's value that differs from its market value or its book value, called intrinsic value, which is Alpha Tau's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Alpha Tau's market value can be influenced by many factors that don't directly affect Alpha Tau's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Alpha Tau's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Alpha Tau should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Alpha Tau's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Alpha Tau 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Alpha Tau's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Alpha Tau.
| 11/19/2025 |
| 02/17/2026 |
If you would invest 0.00 in Alpha Tau on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Alpha Tau Medical or generate 0.0% return on investment in Alpha Tau over 90 days. Alpha Tau is related to or competes with Cellectis, Alto Neuroscience, Genelux Common, Larimar Therapeutics, AC Immune, DiaMedica Therapeutics, and Amarin PLC. Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercial... More
Alpha Tau Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Alpha Tau's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Alpha Tau Medical upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.66 | |||
| Information Ratio | 0.1799 | |||
| Maximum Drawdown | 29.36 | |||
| Value At Risk | (7.29) | |||
| Potential Upside | 10.48 |
Alpha Tau Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alpha Tau's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Alpha Tau's standard deviation. In reality, there are many statistical measures that can use Alpha Tau historical prices to predict the future Alpha Tau's volatility.| Risk Adjusted Performance | 0.1638 | |||
| Jensen Alpha | 0.8676 | |||
| Total Risk Alpha | 0.6512 | |||
| Sortino Ratio | 0.216 | |||
| Treynor Ratio | 0.3209 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Alpha Tau's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Alpha Tau February 17, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1638 | |||
| Market Risk Adjusted Performance | 0.3309 | |||
| Mean Deviation | 4.17 | |||
| Semi Deviation | 3.72 | |||
| Downside Deviation | 4.66 | |||
| Coefficient Of Variation | 519.71 | |||
| Standard Deviation | 5.6 | |||
| Variance | 31.32 | |||
| Information Ratio | 0.1799 | |||
| Jensen Alpha | 0.8676 | |||
| Total Risk Alpha | 0.6512 | |||
| Sortino Ratio | 0.216 | |||
| Treynor Ratio | 0.3209 | |||
| Maximum Drawdown | 29.36 | |||
| Value At Risk | (7.29) | |||
| Potential Upside | 10.48 | |||
| Downside Variance | 21.72 | |||
| Semi Variance | 13.86 | |||
| Expected Short fall | (4.78) | |||
| Skewness | 0.7318 | |||
| Kurtosis | 1.04 |
Alpha Tau Medical Backtested Returns
Alpha Tau is moderately volatile given 3 months investment horizon. Alpha Tau Medical secures Sharpe Ratio (or Efficiency) of 0.22, which signifies that the company had a 0.22 % return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.29% are justified by taking the suggested risk. Use Alpha Tau Mean Deviation of 4.17, risk adjusted performance of 0.1638, and Downside Deviation of 4.66 to evaluate company specific risk that cannot be diversified away. Alpha Tau holds a performance score of 17 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 3.33, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Alpha Tau will likely underperform. Use Alpha Tau value at risk, as well as the relationship between the kurtosis and market facilitation index , to analyze future returns on Alpha Tau.
Auto-correlation | 0.59 |
Modest predictability
Alpha Tau Medical has modest predictability. Overlapping area represents the amount of predictability between Alpha Tau time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Alpha Tau Medical price movement. The serial correlation of 0.59 indicates that roughly 59.0% of current Alpha Tau price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.59 | |
| Spearman Rank Test | 0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.32 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Alpha Stock Analysis
When running Alpha Tau's price analysis, check to measure Alpha Tau's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alpha Tau is operating at the current time. Most of Alpha Tau's value examination focuses on studying past and present price action to predict the probability of Alpha Tau's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alpha Tau's price. Additionally, you may evaluate how the addition of Alpha Tau to your portfolios can decrease your overall portfolio volatility.